Smith & Nephew plc (LON:SN) shares fell 0% during mid-day trading on Tuesday . The company traded as low as GBX 1,384 ($18.20) and last traded at GBX 1,388.11 ($18.26). 3,960,000 shares changed hands during mid-day trading, an increase of 16% from the average session volume of 3,420,000 shares. The stock had previously closed at GBX 1,388.11 ($18.26).

A number of brokerages have recently issued reports on SN. J P Morgan Chase & Co lifted their price target on Smith & Nephew plc from GBX 1,280 ($16.84) to GBX 1,361 ($17.90) and gave the company a “neutral” rating in a report on Monday, July 31st. Deutsche Bank AG restated a “buy” rating on shares of Smith & Nephew plc in a research note on Friday, October 13th. Citigroup Inc. restated a “sell” rating and set a GBX 1,160 ($15.26) target price on shares of Smith & Nephew plc in a research note on Monday, July 10th. Jefferies Group LLC restated a “buy” rating and set a GBX 1,515 ($19.93) target price on shares of Smith & Nephew plc in a research note on Thursday, October 12th. Finally, HSBC Holdings plc restated a “hold” rating and set a GBX 1,320 ($17.36) target price on shares of Smith & Nephew plc in a research note on Monday, July 10th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of GBX 1,303.92 ($17.15).

In other news, insider Virginia Bottomley purchased 223 shares of the stock in a transaction on Wednesday, August 16th. The stock was bought at an average price of GBX 1,380 ($18.15) per share, with a total value of £3,077.40 ($4,047.61).

COPYRIGHT VIOLATION NOTICE: “Smith & Nephew plc (SN) Stock Price Down 0%” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/11/07/smith-nephew-plc-sn-stock-price-down-0.html.

Smith & Nephew plc Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Receive News & Stock Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related stocks with our FREE daily email newsletter.